跳至主要内容
临床试验/NCT03166345
NCT03166345已完成不适用

Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium For IVF Women

Ibn Sina Hospital4 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2017年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
4
主要终点
Mean Diameter of endometrial thickness

研究概览

简要总结

Platelets rich plasma is simple source of growth factors and cytokines that can regulate endometrial growth for subgroup of thin endometrium women. It is an autologous source of this enhancing factors; therefore, there os no risk of using it within the same participant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women with thin endometrium

排除标准

  • serum positive hepatitis B and C women

研究组 & 干预措施

No intervention

No Intervention

The control arm.

PRP injection into Uterine Cavity

Experimental

PRP injection into Uterine Cavity For Treatment of Thin Endometrium

干预措施: Treatment of Thin Endometrium (Other)

CSF (colony stimulating factor)

Experimental

CSF for Treatment of Thin Endometrium

干预措施: Treatment of Thin Endometrium (Other)

结局指标

主要结局

Mean Diameter of endometrial thickness

时间窗: 2 days

How the endometrium would respond after 2 days of PRP

次要结局

  • Clinical pregnancy rate(4 weeks or beyond after embryo Transfer)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Muhammad Fawzy

IVF Lab Director

Ibn Sina Hospital

研究点 (4)

Loading locations...

相似试验